Key facts
- It has raised $105.4M; the latest was Later Stage VC ($10.0M) in May 2025.
- Notable investors include Qiming Venture Partners, OrbiMed, YuanBio Venture Capital, Huikai Zhenghe Investment, Cenova Capital — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Pulnovo Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Pulnovo Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Pulnovo Medical
Developer of pulmonary hypertension ablation catheter and instrument designed to improve patients' life resilience. The company develops a pulse radiofrequency ablation catheter and ablation instrument for the treatment of pulmonary hypertension, enabling advanced treatment for pulmonary hypertension and heart failure's patients.
- Sector
- Healthcare
- HQ
- Wuxi, China
- Founded
- 2013
- Employees
- 100
- Website
- pulnovomed.com/
- Ownership
- Privately Held (backing)
Pulnovo Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Pulnovo Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Pulnovo Medical in its N-PORT filings yet. We sweep new filings monthly.